Science 23 July 1993: Vol. 261. no. 5120, pp. 469 - 472 DOI: 10.1126/science.8332912

Prev | Table of Contents | Next

Articles

Phospholipids mediated conversion of HDLs generates specific apoA-II pre-{beta} mobility particles.

M. Wroblewska, B. Kortas-Stempak, A. Szutowicz, and T. Badzio (2009)
J. Lipid Res. 50, 667-675
 |  Abstract »  |  Full Text »  |  PDF »

A new mouse mutant for the LDL receptor identified using ENU mutagenesis.

K. L. Svenson, N. Ahituv, R. S. Durgin, H. Savage, P. A. Magnani, O. Foreman, B. Paigen, and L. L. Peters (2008)
J. Lipid Res. 49, 2452-2462
 |  Abstract »  |  Full Text »  |  PDF »

Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome.

P. S. Green, T. Vaisar, S. Pennathur, J. J. Kulstad, A. B. Moore, S. Marcovina, J. Brunzell, R. H. Knopp, X.-Q. Zhao, and J. W. Heinecke (2008)
Circulation 118, 1259-1267
 |  Abstract »  |  Full Text »  |  PDF »

HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress.

X. Moren, S. Deakin, M.-L. Liu, M.-R. Taskinen, and R. W. James (2008)
J. Lipid Res. 49, 1246-1253
 |  Abstract »  |  Full Text »  |  PDF »

Laboratory Assessment of HDL Heterogeneity and Function.

R. Movva and D. J. Rader (2008)
Clin. Chem. 54, 788-800
 |  Abstract »  |  Full Text »  |  PDF »

Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance.

L. W. Castellani, C. N. Nguyen, S. Charugundla, M. M. Weinstein, C. X. Doan, W. S. Blaner, N. Wongsiriroj, and A. J. Lusis (2008)
J. Biol. Chem. 283, 11633-11644
 |  Abstract »  |  Full Text »  |  PDF »

Apolipoprotein A-II Is Inversely Associated With Risk of Future Coronary Artery Disease.

R. S. Birjmohun, G. M. Dallinga-Thie, J. A. Kuivenhoven, E. S.G. Stroes, J. D. Otvos, N. J. Wareham, R. Luben, J. J.P. Kastelein, K.-T. Khaw, and S. M. Boekholdt (2007)
Circulation 116, 2029-2035
 |  Abstract »  |  Full Text »  |  PDF »

Recipes for Creating Animal Models of Diabetic Cardiovascular Disease.

W. Hsueh, E. D. Abel, J. L. Breslow, N. Maeda, R. C. Davis, E. A. Fisher, H. Dansky, D. A. McClain, R. McIndoe, M. K. Wassef, et al. (2007)
Circ. Res. 100, 1415-1427
 |  Abstract »  |  Full Text »  |  PDF »

The Structure of Apolipoprotein A-II in Discoidal High Density Lipoproteins.

R. A. G. D. Silva, L. A. Schneeweis, S. C. Krishnan, X. Zhang, P. H. Axelsen, and W. S. Davidson (2007)
J. Biol. Chem. 282, 9713-9721
 |  Abstract »  |  Full Text »  |  PDF »

Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis.

A. Kontush and M. J. Chapman (2006)
Pharmacol. Rev. 58, 342-374
 |  Abstract »  |  Full Text »  |  PDF »

Overexpression of lysosomal Acid lipase and other proteins in atherosclerosis..

O. Zschenker, T. Illies, and D. Ameis (2006)
J. Biochem. 140, 23-38
 |  Abstract »  |  Full Text »  |  PDF »

Trans-10, cis-12- and cis-9, trans-11-Conjugated Linoleic Acid Isomers Selectively Modify HDL-Apolipoprotein Composition in Apolipoprotein E Knockout Mice.

J. M. Arbones-Mainar, M. A. Navarro, S. Acin, M. A. Guzman, C. Arnal, J. C. Surra, R. Carnicer, H. M. Roche, and J. Osada (2006)
J. Nutr. 136, 353-359
 |  Abstract »  |  Full Text »  |  PDF »

Impact of Short-Term Administration of High-Density Lipoproteins and Atorvastatin on Atherosclerosis in Rabbits.

S. J. Nicholls, B. Cutri, S. G. Worthley, P. Kee, K.-A. Rye, S. Bao, and P. J. Barter (2005)
Arterioscler Thromb Vasc Biol 25, 2416-2421
 |  Abstract »  |  Full Text »  |  PDF »

ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease.

J. F. Oram and J. W. Heinecke (2005)
Physiol Rev 85, 1343-1372
 |  Abstract »  |  Full Text »  |  PDF »

Overexpression of Human Apolipoprotein A-II in Transgenic Mice Does Not Impair Macrophage-Specific Reverse Cholesterol Transport In Vivo.

N. Rotllan, V. Ribas, L. Calpe-Berdiel, J. M. Martin-Campos, F. Blanco-Vaca, and J. C. Escola-Gil (2005)
Arterioscler Thromb Vasc Biol 25, e128-e132
 |  Abstract »  |  Full Text »  |  PDF »

Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II.

L. W. Castellani, P. Gargalovic, M. Febbraio, S. Charugundla, M.-L. Jien, and A. J. Lusis (2004)
J. Lipid Res. 45, 2377-2387
 |  Abstract »  |  Full Text »  |  PDF »

Human Apolipoprotein A-II Enrichment Displaces Paraoxonase From HDL and Impairs Its Antioxidant Properties: A New Mechanism Linking HDL Protein Composition and Antiatherogenic Potential.

V. Ribas, J. L. Sanchez-Quesada, R. Anton, M. Camacho, J. Julve, J. C. Escola-Gil, L. Vila, J. Ordonez-Llanos, and F. Blanco-Vaca (2004)
Circ. Res. 95, 789-797
 |  Abstract »  |  Full Text »  |  PDF »

Genetic contributors to lipoprotein cholesterol levels in an intercross of 129S1/SvImJ and RIIIS/J inbred mice.

M. A. Lyons, R. Korstanje, R. Li, K. A. Walsh, G. A. Churchill, M. C. Carey, and B. Paigen (2004)
Physiol Genomics 17, 114-121
 |  Abstract »  |  Full Text »  |  PDF »

ApoA-II modulates the association of HDL with class B scavenger receptors SR-BI and CD36.

M. C. de Beer, L. W. Castellani, L. Cai, A. J. Stromberg, F. C. de Beer, and D. R. van der Westhuyzen (2004)
J. Lipid Res. 45, 706-715
 |  Abstract »  |  Full Text »  |  PDF »

Apolipoprotein A-I Deficiency Results in Markedly Increased Atherosclerosis in Mice Lacking the LDL Receptor.

R. E. Moore, M.-a. Kawashiri, K. Kitajima, A. Secreto, J. S. Millar, D. Pratico, and D. J. Rader (2003)
Arterioscler Thromb Vasc Biol 23, 1914-1920
 |  Abstract »  |  Full Text »  |  PDF »

Using Mice to Dissect Genetic Factors in Atherosclerosis.

H. Allayee, A. Ghazalpour, and A. J. Lusis (2003)
Arterioscler Thromb Vasc Biol 23, 1501-1509
 |  Abstract »  |  Full Text »  |  PDF »

Biochemical and Genetic Association of Plasma Apolipoprotein A-II Levels With Familial Combined Hyperlipidemia.

H. Allayee, L. W. Castellani, R. M. Cantor, T. W.A. de Bruin, and A. J. Lusis (2003)
Circ. Res. 92, 1262-1267
 |  Abstract »  |  Full Text »  |  PDF »

Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice.

P. M. Cazita, J. A. Berti, C. Aoki, M. Gidlund, L. M. Harada, V. S. Nunes, E. C. R. Quintao, and H. C. F. Oliveira (2003)
J. Lipid Res. 44, 33-40
 |  Abstract »  |  Full Text »  |  PDF »

Mechanisms of HDL deficiency in mice overexpressing human apoA-II.

J. Julve, J. C. Escola-Gil, V. Ribas, F. Gonzalez-Sastre, J. Ordonez-Llanos, J. L. Sanchez-Quesada, and F. Blanco-Vaca (2002)
J. Lipid Res. 43, 1734-1742
 |  Abstract »  |  Full Text »  |  PDF »

Quantitative Trait Loci and Candidate Genes Regulating HDL Cholesterol: A Murine Chromosome Map.

X. Wang and B. Paigen (2002)
Arterioscler Thromb Vasc Biol 22, 1390-1401
 |  Abstract »  |  Full Text »  |  PDF »

Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II.

E. Boisfer, D. Stengel, D. Pastier, P. M. Laplaud, N. Dousset, E. Ninio, and A.-D. Kalopissis (2002)
J. Lipid Res. 43, 732-741
 |  Abstract »  |  Full Text »  |  PDF »

Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis.

O. Barbier, I. P. Torra, Y. Duguay, C. Blanquart, J.-C. Fruchart, C. Glineur, and B. Staels (2002)
Arterioscler Thromb Vasc Biol 22, 717-726
 |  Abstract »  |  Full Text »  |  PDF »

ApoA-II Versus ApoA-I: Two for One Is Not Always a Good Deal.

L. W. Castellani and A. J. Lusis (2001)
Arterioscler Thromb Vasc Biol 21, 1870-1872
 |  Full Text »  |  PDF »

Arg123-Tyr166 Domain of Human ApoA-I Is Critical for HDL-Mediated Inhibition of Macrophage Homing and Early Atherosclerosis in Mice.

P. Holvoet, K. Peeters, S. Lund-Katz, A. Mertens, P. Verhamme, R. Quarck, D. Stengel, M. Lox, E. Deridder, H. Bernar, et al. (2001)
Arterioscler Thromb Vasc Biol 21, 1977-1983
 |  Abstract »  |  Full Text »  |  PDF »

Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II.

P. K. Shah, S. Kaul, J. Nilsson, and B. Cercek (2001)
Circulation 104, 2498-2502
 |  Full Text »  |  PDF »

Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein.

F. Blanco-Vaca, J. C. Escola-Gil, J. M. Martin-Campos, and J. Julve (2001)
J. Lipid Res. 42, 1727-1739
 |  Abstract »  |  Full Text »  |  PDF »

Human Evidence That the Apolipoprotein A-II Gene Is Implicated in Visceral Fat Accumulation and Metabolism of Triglyceride-Rich Lipoproteins.

F. M. van 't Hooft, G. Ruotolo, S. Boquist, U. de Faire, G. Eggertsen, and A. Hamsten (2001)
Circulation 104, 1223-1228
 |  Abstract »  |  Full Text »  |  PDF »

In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.

C. C. Hedrick, L. W. Castellani, H. Wong, and A. J. Lusis (2001)
J. Lipid Res. 42, 563-570
 |  Abstract »  |  Full Text »

HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids.

M. Navab, J. A. Berliner, G. Subbanagounder, S. Hama, A. J. Lusis, L. W. Castellani, S. Reddy, D. Shih, W. Shi, A. D. Watson, et al. (2001)
Arterioscler Thromb Vasc Biol 21, 481-488
 |  Abstract »  |  Full Text »  |  PDF »

Heme Oxygenase-1 Inhibits Atherosclerotic Lesion Formation in LDL-Receptor Knockout Mice.

K. Ishikawa, D. Sugawara, X.-p. Wang, K. Suzuki, H. Itabe, Y. Maruyama, and A. J. Lusis (2001)
Circ. Res. 88, 506-512
 |  Abstract »  |  Full Text »  |  PDF »

Studies With Apolipoprotein A-II Transgenic Mice Indicate a Role for HDLs in Adiposity and Insulin Resistance.

L. W. Castellani, A. M. Goto, and A. J. Lusis (2001)
Diabetes 50, 643-651
 |  Abstract »  |  Full Text »

ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance.

J. C. Escolà-Gil, J. Julve, A. Marzal-Casacuberta, J. Ordóñez-Llanos, F. González-Sastre, and F. Blanco-Vaca (2001)
J. Lipid Res. 42, 241-248
 |  Abstract »  |  Full Text »

High Density Lipoproteins and Arteriosclerosis : Role of Cholesterol Efflux and Reverse Cholesterol Transport.

A. von Eckardstein, J.-R. Nofer, and G. Assmann (2001)
Arterioscler Thromb Vasc Biol 21, 13-27
 |  Abstract »  |  Full Text »  |  PDF »

Advanced Atherosclerotic Lesions in the Innominate Artery of the ApoE Knockout Mouse.

M. E. Rosenfeld, P. Polinsky, R. Virmani, K. Kauser, G. Rubanyi, and S. M. Schwartz (2000)
Arterioscler Thromb Vasc Biol 20, 2587-2592
 |  Abstract »  |  Full Text »  |  PDF »

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.

M. Navab, S. Y. Hama, C. J. Cooke, G. M. Anantharamaiah, M. Chaddha, L. Jin, G. Subbanagounder, K. F. Faull, S. T. Reddy, N. E. Miller, et al. (2000)
J. Lipid Res. 41, 1481-1494
 |  Abstract »  |  Full Text »

Thrombasthenic mice generated by replacement of the integrin alpha IIb gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment.

D. T.-L. Roux, V. Roullot, C. Poujol, T. Kortulewski, P. Nurden, and G. Marguerie (2000)
Blood 96, 1399-1408
 |  Abstract »  |  Full Text »  |  PDF »

Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype.

R. W. Mahley, J. Pépin, K. E. Palaoglu, M. J. Malloy, J. P. Kane, and T. P. Bersot (2000)
J. Lipid Res. 41, 1290-1301
 |  Abstract »  |  Full Text »

Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.

J. C. Escolà-Gil, J. Julve, A. Marzal-Casacuberta, J. Ordóñez-Llanos, F. González-Sastre, and F. Blanco-Vaca (2000)
J. Lipid Res. 41, 1328-1338
 |  Abstract »  |  Full Text »

Apolipoprotein AII Enrichment of HDL Enhances Their Affinity for Class B Type I Scavenger Receptor but Inhibits Specific Cholesteryl Ester Uptake.

A. Pilon, O. Briand, S. Lestavel, C. Copin, Z. Majd, J.-C. Fruchart, G. Castro, and V. Clavey (2000)
Arterioscler Thromb Vasc Biol 20, 1074-1081
 |  Abstract »  |  Full Text »  |  PDF »

Intravascular Free Tissue Factor Pathway Inhibitor Is Inversely Correlated With HDL Cholesterol and Postheparin Lipoprotein Lipase but Proportional to Apolipoprotein A-II.

A. Kawaguchi, Y. Miyao, T. Noguchi, H. Nonogi, M. Yamagishi, K. Miyatake, Y. Kamikubo, K. Kumeda, M. Tsushima, A. Yamamoto, et al. (2000)
Arterioscler Thromb Vasc Biol 20, 251-258
 |  Abstract »  |  Full Text »  |  PDF »

Mouse Senile Amyloid Deposition Is Suppressed by Adenovirus-Mediated Overexpression of Amyloid-Resistant Apolipoprotein A-II.

T. Chiba, K. Kogishi, J. Wang, C. Xia, T. Matsushita, J.-i. Miyazaki, I. Saito, M. Hosokawa, and K. Higuchi (1999)
Am. J. Pathol. 155, 1319-1326
 |  Abstract »  |  Full Text »  |  PDF »

Acute Changes in Serum Lipids and Lipoprotein Subclasses in Triathletes as Assessed by Proton Nuclear Magnetic Resonance Spectroscopy.

H. H. Yu, G. S. Ginsburg, M. L. O'Toole, J. D. Otvos, P. S. Douglas, and N. Rifai (1999)
Arterioscler Thromb Vasc Biol 19, 1945-1949
 |  Abstract »  |  Full Text »  |  PDF »

Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice.

H. M. Dansky, S. A. Charlton, J. L. Sikes, S. C. Heath, R. Simantov, L. F. Levin, P. Shu, K. J. Moore, J. L. Breslow, and J. D. Smith (1999)
Arterioscler Thromb Vasc Biol 19, 1960-1968
 |  Abstract »  |  Full Text »  |  PDF »

SREBP-1 Binds to Multiple Sites and Transactivates the Human ApoA-II Promoter In Vitro : SREBP-1 Mutants Defective in DNA Binding or Transcriptional Activation Repress ApoA-II Promoter Activity.

P. Pissios, H.-Y. Kan, S. Nagaoka, and V. I. Zannis (1999)
Arterioscler Thromb Vasc Biol 19, 1456-1469
 |  Abstract »  |  Full Text »  |  PDF »

Role of Group II Secretory Phospholipase A2 in Atherosclerosis : 1. Increased Atherogenesis and Altered Lipoproteins in Transgenic Mice Expressing Group IIa Phospholipase A2.

B. Ivandic, L. W. Castellani, X.-P. Wang, J.-H. Qiao, M. Mehrabian, M. Navab, A. M. Fogelman, D. S. Grass, M. E. Swanson, M. C. de Beer, et al. (1999)
Arterioscler Thromb Vasc Biol 19, 1284-1290
 |  Abstract »  |  Full Text »  |  PDF »

Role of Group II Secretory Phospholipase A2 in Atherosclerosis : 2. Potential Involvement of Biologically Active Oxidized Phospholipids.

N. Leitinger, A. D. Watson, S. Y. Hama, B. Ivandic, J.-H. Qiao, J. Huber, K. F. Faull, D. S. Grass, M. Navab, A. M. Fogelman, et al. (1999)
Arterioscler Thromb Vasc Biol 19, 1291-1298
 |  Abstract »  |  Full Text »  |  PDF »

Overexpression of Human Apolipoprotein A-II in Mice Induces Hypertriglyceridemia Due to Defective Very Low Density Lipoprotein Hydrolysis.

E. Boisfer, G. Lambert, V. Atger, N. Q. Tran, D. Pastier, C. Benetollo, J.-F. Trottier, I. Beaucamps, M. Antonucci, M. Laplaud, et al. (1999)
J. Biol. Chem. 274, 11564-11572
 |  Abstract »  |  Full Text »  |  PDF »

Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo.

S. Braschi, T. A-M. Neville, M.-C. Vohl, and D. L. Sparks (1999)
J. Lipid Res. 40, 522-532
 |  Abstract »  |  Full Text »

High density lipoprotein receptors, binding proteins, and ligands.

N. H. Fidge (1999)
J. Lipid Res. 40, 187-201
 |  Abstract »  |  Full Text »

Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.

P. W. Baker, K.-A. Rye, J. R. Gamble, M. A. Vadas, and P. J. Barter (1999)
J. Lipid Res. 40, 345-353
 |  Abstract »  |  Full Text »

Paraoxonase PON1 Polymorphism Leu-Met54 Is Associated With Carotid Atherosclerosis : Results of the Austrian Stroke Prevention Study.

H. Schmidt, R. Schmidt, K. Niederkorn, A. Gradert, M. Schumacher, N. Watzinger, H.-P. Hartung, and G. M. Kostner (1998)
Stroke 29, 2043-2048
 |  Abstract »  |  Full Text »  |  PDF »

Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis.

P. Carmeliet, L. Moons, and D. Collen (1998)
Cardiovasc Res 39, 8-33
 |  Abstract »  |  Full Text »  |  PDF »

Estradiol Stimulates Apolipoprotein A-I– but Not A-II–Containing Particle Synthesis and Secretion by Stimulating mRNA Transcription Rate in Hep G2 Cells.

F.-Y. Jin, V. S. Kamanna, and M. L. Kashyap (1998)
Arterioscler Thromb Vasc Biol 18, 999-1006
 |  Abstract »  |  Full Text »  |  PDF »

High-density lipoprotein particles are large in patients with variant angina.

K. Miwa, N. Yoshida, K. Nakagawa, and H. Inoue (1998)
Cardiovasc Res 37, 729-737
 |  Abstract »  |  Full Text »  |  PDF »

Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet.

J. C. Escolà-Gil, A. Marzal-Casacuberta, J. Julve-Gil, B. Y. Ishida, J. Ordóñez-Llanos, L. Chan, F. González-Sastre, and F. Blanco-Vaca (1998)
J. Lipid Res. 39, 457-462
 |  Abstract »  |  Full Text »

Binding of phospholipid transfer protein (PLTP) to apolipoproteins A-I and A-II: location of a PLTP binding domain in the amino terminal region of apoA-I.

P. J. Pussinen, M. Jauhiainen, J. Metso, L. E. Pyle, Y. L. Marcel, N. H. Fidge, and C. Ehnholm (1998)
J. Lipid Res. 39, 152-161
 |  Abstract »  |  Full Text »

Effects of Adenovirus-Mediated Human Apo A-I Gene Transfer on Neointima Formation After Endothelial Denudation in Apo E–Deficient Mice.

B. De Geest, Z. Zhao, D. Collen, and P. Holvoet (1997)
Circulation 96, 4349-4356
 |  Abstract »  |  Full Text »

The Effect of Apolipoprotein A-II on the Structure and Function of Apolipoprotein A-I in a Homogeneous Reconstituted High Density Lipoprotein Particle.

D. M. Durbin and A. Jonas (1997)
J. Biol. Chem. 272, 31333-31339
 |  Abstract »  |  Full Text »  |  PDF »

Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation.

D. W. Borhani, D. P. Rogers, J. A. Engler, and C. G. Brouillette (1997)
PNAS 94, 12291-12296
 |  Abstract »  |  Full Text »  |  PDF »

A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism.

A. Rigotti, B. L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger (1997)
PNAS 94, 12610-12615
 |  Abstract »  |  Full Text »  |  PDF »

Association Between Serum Amyloid A Proteins and Coronary Artery Disease : Evidence From Two Distinct Arteriosclerotic Processes.

A. I. Fyfe, L.S. Rothenberg, F. C. DeBeer, R. M. Cantor, J. I. Rotter, and A. J. Lusis (1997)
Circulation 96, 2914-2919
 |  Abstract »  |  Full Text »

17ß-Estradiol Prevents Fatty Streak Formation in Apolipoprotein E–Deficient Mice.

R. Elhage, J.-F. Arnal, M.-T. Pieraggi, N. Duverger, C. Fievet, J.-C. Faye, and F. Bayard (1997)
Arterioscler Thromb Vasc Biol 17, 2679-2684
 |  Abstract »  |  Full Text »

Apolipoprotein A-IFIN (Leu159->Arg) Mutation Affects Lecithin : Cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not Cholesterol Efflux From Fibroblasts.

H. E. Miettinen, M. Jauhiainen, H. Gylling, S. Ehnholm, A. Palomaki, T. A. Miettinen, and K. Kontula (1997)
Arterioscler Thromb Vasc Biol 17, 3021-3032
 |  Abstract »  |  Full Text »

Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility.

W. Weng and J. L. Breslow (1996)
PNAS 93, 14788-14794
 |  Abstract »  |  Full Text »  |  PDF »

Adenovirus-Mediated Gene Transfer as an In Vivo Probe of Lipoprotein Metabolism.

J. M. Leiden (1996)
Circulation 94, 2046-2051
 |  Full Text »

Can Genes Prevent Atherosclerosis?.

J. M. Hoeg (1996)
JAMA 276, 989-992
 |  Abstract »  |  PDF »

Gemfibrozil Stimulates Apolipoprotein A-I Synthesis and Secretion by Stabilization of mRNA Transcripts in Human Hepatoblastoma Cell Line (Hep G2).

F.-Y. Jin, V. S. Kamanna, M.-Y. Chuang, K. Morgan, and M. L. Kashyap (1996)
Arterioscler Thromb Vasc Biol 16, 1052-1062
 |  Abstract »  |  Full Text »

Apolipoprotein A-II Influences the Substrate Properties of Human HDL2 and HDL3 for Hepatic Lipase.

H.-O. Mowri, J. R. Patsch, A. M. Gotto Jr, and W. Patsch (1996)
Arterioscler Thromb Vasc Biol 16, 755-762
 |  Abstract »  |  Full Text »

Transcriptional Regulation of the Genes Involved in Lipoprotein Transport : The Role of Proximal Promoters and Long-range Regulatory Elements and Factors in Apolipoprotein Gene Regulation.

D. Kardassis, M. Laccotripe, I. Talianidis, and V. Zannis (1996)
Hypertension 27, 980-1008
 |  Full Text »

Functional Lecithin:Cholesterol Acyltransferase Deficiency and High Density Lipoprotein Deficiency in Transgenic Mice Overexpressing Human Apolipoprotein A-II.

A. Marzal-Casacuberta, F. Blanco-Vaca, B. Y. Ishida, J. Julve-Gil, J. Shen, S. Calvet-Márquez, F. González-Sastre, and L. Chan (1996)
J. Biol. Chem. 271, 6720-6728
 |  Abstract »  |  Full Text »  |  PDF »

Contrasting in Vivo Effects of Murine and Human Apolipoprotein A-II.

E. L. Gong, L. J. Stoltzfus, C. M. Brion, D. Murugesh, and E. M. Rubin (1996)
J. Biol. Chem. 271, 5984-5987
 |  Abstract »  |  Full Text »  |  PDF »

Oral Estrogen Replacement Therapy in Postmenopausal Women Selectively Raises Levels and Production Rates of Lipoprotein A-I and Lowers Hepatic Lipase Activity Without Lowering the Fractional Catabolic Rate.

E. A. Brinton (1996)
Arterioscler Thromb Vasc Biol 16, 431-440
 |  Abstract »  |  Full Text »

Only the Two End Helixes of Eight Tandem Amphipathic Helical Domains of Human Apo A-I Have Significant Lipid Affinity : Implications for HDL Assembly.

M. N. Palgunachari, V. K. Mishra, S. Lund-Katz, M. C. Phillips, S. O. Adeyeye, S. Alluri, G.M. Anantharamaiah, and J. P. Segrest (1996)
Arterioscler Thromb Vasc Biol 16, 328-338
 |  Abstract »  |  Full Text »

Apolipoprotein A-I Deficiency : Biochemical and Metabolic Characteristics.

D. S. Ng, C. Vezina, T. S. Wolever, A. Kuksis, R. A. Hegele, and P. W. Connelly (1995)
Arterioscler Thromb Vasc Biol 15, 2157-2164
 |  Abstract »  |  Full Text »

Cholesterol Efflux, Cholesterol Esterification, and Cholesteryl Ester Transfer by LpA-I and LpA-I/A-II in Native Plasma.

Y. Huang, A. von Eckardstein, S. Wu, and G. Assmann (1995)
Arterioscler Thromb Vasc Biol 15, 1412-1418
 |  Abstract »  |  Full Text »

Apolipoprotein A-II Production Rate Is a Major Factor Regulating the Distribution of Apolipoprotein A-I Among HDL Subclasses LpA-I and LpA-I:A-II in Normolipidemic Humans.

K. Ikewaki, L. A. Zech, M. Kindt, H. B. Brewer Jr, and D. J. Rader (1995)
Arterioscler Thromb Vasc Biol 15, 306-312
 |  Abstract »  |  Full Text »

The Role of Lipoprotein A-I and Lipoprotein A-I/A-II in Predicting Coronary Artery Disease.

T. O'Brien, T. T. Nguyen, B. J. Hallaway, D. Hodge, K. Bailey, D. Holmes, and B. A. Kottke (1995)
Arterioscler Thromb Vasc Biol 15, 228-231
 |  Abstract »  |  Full Text »

Genetic Models of Human Vascular Disease.

V. J. Dzau, G. H. Gibbons, B. K. Kobilka, R. M. Lawn, and R. E. Pratt (1995)
Circulation 91, 521-531
 |  Abstract »  |  Full Text »

Apolipoprotein A-II Modulates the Binding and Selective Lipid Uptake of Reconstituted High Density Lipoprotein by Scavenger Receptor BI.

M. C. de Beer, D. M. Durbin, L. Cai, N. Mirocha, A. Jonas, N. R. Webb, F. C. de Beer, and D. R. van der Westhuyzen (2001)
J. Biol. Chem. 276, 15832-15839
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products